European pharma stocks decline as Trump reiterates tariff plans
Source: SeekingAlpha
2025-04-09 06:02:04 ET
More on European drugmakers
- Novartis After Sandoz: The Business Without Generics
- AstraZeneca's Innovation Ecosystem: From Blockbusters To The Next Generation Of Therapy
- Novo Nordisk: Not As Bullish As Many
- Daiichi Sankyo and AstraZeneca get EU approval for Datroway
- Novo reportedly eyeing $1.09B investment in Brazil to expand obesity drug production
Read the full article on Seeking Alpha
For further details see:
European pharma stocks decline as Trump reiterates tariff plans
Novartis AG
NASDAQ: NVS
NVS Trading
-1.0% G/L:
$154.46 Last:
47,719 Volume:
$154.55 Open:
NVS Latest News
February 24, 2026 04:52:00 pm
Could Novartis Stock Quietly Help You Build a Millionaire Retirement Portfolio?
February 22, 2026 03:07:00 pm
Novartis: This Big Pharma Giant Could Be a Sleep?at?Night Core Holding for Decades
NVS Stock Data
$303,205,301,793
1,889,070,162
N/A
868
N/A
Pharmaceuticals
Healthcare
CH
Basel
